VA PHARMA
ActiveActs, filings and financial milestones
Deadline for the 2026 accounts:
2026
27-08
abbreviated format · 27 days late
2025
01-08
full format · 1 day late
2024
31-12
Financial
Highest result from 2018 to 2025net €78,462 ▲3.5%
The operating result of €126,457 and the net result of €78,462 are both a record.
30-08
full format · 30 days late
29-05
full format · 303 days late
01-02
Gazette deed
Amendment of the articles · Legal-form change · Resignations & appointments · MiscellaneousResignation: VANLAUTEM François (manager) · Appointment: VA IMMO (director and managing director) · Permanent representatives: VANLAUTEM François and ANDRÉ Maureen Anne Kathleen12 points ▸
Gazette deed
Amendment of the articles · Legal-form change · Resignations & appointments · Miscellaneous
Resignation: VANLAUTEM François (manager) · Appointment: VA IMMO (director and managing director) · Permanent representatives: VANLAUTEM François and ANDRÉ Maureen Anne Kathleen12 points ▸
- General meeting, 24-01-2024
- Incorporation, 18-12-2012
- VANLAUTEM François holds 50 shares
- ANDRÉ Maureen Anne Kathleen holds 50 shares
- Other provision, “régime matrimonial, séparation des biens” (deed in French)
- Amendment of the articles, mentioned 2 times in the deed
- Capital conversion, “compte de capitaux propres statutairement disponible” (deed in French)
- Other provision, “distribution d'un dividende prélevé sur bénéfice exercice en cours ou bénéfice exercice précédent dont comptes non encore approuvés, autorisation acompte sur di…” (deed in French)
- Director resignation, VANLAUTEM François (manager)
- Director appointment, VA IMMO (director (not named in the articles) and managing director), mentioned 2 times in the deed
- Permanent representative, VANLAUTEM François (director and permanent representative)
- Permanent representative, ANDRÉ Maureen Anne Kathleen (director and permanent representative)
2023
31-12
Financial
Equity above €200,000equity €272,446 ▲38.5%
After 2 profitable years in a row, equity reaches €272,446.
2022
31-12
Financial
Back to profitnet €64,181
The net result is €64,181, after 3 loss-making years.
31-12
Financial
Equity above €150,000equity €196,665 ▲48.4%
Equity rises from €132,484 to €196,665.
30-08
full format · 30 days late
2021
31-08
full format · 31 days late
2020
07-12
full format · 129 days late
Show earlier events
2019
31-12
Financial
Weakest financial yearnet -€38,251
The net result drops to -€38,251, the lowest from 2018 to 2025. It recovers the following year.
20-12
full format · 142 days late
2018
07-11
full format · 99 days late
2017
30-08
micro format · 30 days late
2012
20-12
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
Sources:Publications in the Belgian Official GazetteFilings with the National Bank